RXO (NYSE:RXO) Price Target Raised to $17.00 at Barclays

RXO (NYSE:RXOFree Report) had its target price raised by Barclays from $15.00 to $17.00 in a research note issued to investors on Wednesday,Benzinga reports. They currently have an overweight rating on the stock.

Several other equities analysts have also weighed in on RXO. Wolfe Research upgraded shares of RXO from an “underperform” rating to a “peer perform” rating in a research report on Friday, November 14th. Wall Street Zen cut shares of RXO from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Morgan Stanley upgraded shares of RXO from an “equal weight” rating to an “overweight” rating and set a $19.00 price target on the stock in a research report on Tuesday, November 11th. UBS Group reaffirmed a “neutral” rating on shares of RXO in a report on Sunday, February 8th. Finally, Citigroup raised their price objective on RXO from $15.00 to $18.00 and gave the stock a “neutral” rating in a research note on Monday, February 9th. Four equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $16.47.

View Our Latest Stock Analysis on RXO

RXO Stock Up 0.9%

Shares of RXO stock opened at $16.58 on Wednesday. RXO has a 1 year low of $10.43 and a 1 year high of $20.58. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.27 and a current ratio of 1.27. The business’s fifty day moving average is $14.86 and its 200-day moving average is $15.15. The stock has a market cap of $2.72 billion, a PE ratio of -28.59, a price-to-earnings-growth ratio of 11.55 and a beta of 1.67.

RXO (NYSE:RXOGet Free Report) last announced its quarterly earnings data on Friday, February 6th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.03). The firm had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.50 billion. RXO had a negative net margin of 1.74% and a negative return on equity of 0.44%. The company’s quarterly revenue was down 11.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.06 EPS. Equities analysts expect that RXO will post 0.31 earnings per share for the current fiscal year.

Institutional Trading of RXO

Large investors have recently added to or reduced their stakes in the company. Flagship Harbor Advisors LLC purchased a new stake in shares of RXO in the fourth quarter valued at $25,000. AlphaQuest LLC acquired a new position in RXO during the second quarter valued at $29,000. Geneos Wealth Management Inc. purchased a new stake in RXO in the 1st quarter worth about $30,000. Quarry LP purchased a new stake in RXO in the 3rd quarter worth about $33,000. Finally, Larson Financial Group LLC boosted its position in RXO by 146.5% during the 3rd quarter. Larson Financial Group LLC now owns 2,766 shares of the company’s stock worth $43,000 after acquiring an additional 1,644 shares during the period. 92.73% of the stock is owned by institutional investors and hedge funds.

About RXO

(Get Free Report)

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.

Featured Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.